about
Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRNPrognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men.Non-PCI/CABG therapies for refractory angina.Drug-Eluting Stents: Capable of Saving Lives in Dialysis Patients?Fertility Therapy and Long-Term Cardiovascular Risk: Raising More Questions Than Answers?Right ventricular dysplasia: management and treatment in light of current evidence.Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomesSex-Based Differences in Coronary and Structural Percutaneous Interventions
P50
Q33981146-A824C712-EE17-484B-A4B8-DEDBBFA9B40CQ38826723-C80C0664-3521-4A44-8048-6CFAF75835EFQ47702501-3C9FF47C-B607-4FC3-9FAE-BBD1904BAA9BQ48060124-4A9B753B-DB79-42FC-B7DA-EC9885828499Q50242341-328AE103-AE00-47DE-8991-B64E7772F1EDQ55286785-7096920D-F153-42E2-B46B-EBB4A9CE5E18Q92028318-18F3B43C-A483-4D69-8409-49C302FAE91FQ95643802-EDDD5934-8ED1-4366-902F-59F54E212717
P50
description
researcher (ORCID 0000-0002-9943-3484)
@en
name
Ki Park
@en
type
label
Ki Park
@en
prefLabel
Ki Park
@en
P31
P496
0000-0002-9943-3484